Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Senegal

Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Data Not Available
Cabotegravir (CAB) for PrEP — ViiV
Not Approved
Dapivirine Vaginal Ring (DVR) — Pop Council
Not Approved
Oral PrEP TDF/FTC — Gilead (Truvada)
Approved
Oral PrEP TDF/xTC* - generic
Under Review
Oral PrEP F/TAF — Gilead
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

1 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Est. Cumulative
Initiations:

Total PrEP: 4,445

Oral PrEP: 4,445

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

West Africa Region ROP, 2022

The goal of the 2022 West Africa Region Regional Operational Plan is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the country achieve 95-95-95, and spotlighting HIV prevention and treatment access for all populations in need.
Document

Prevention Market Manager: Analysis of BMGF-Funded PrEP Demonstration Projects

Beginning in 2013, the Bill & Melinda Gates Foundation supported seven early oral PrEP demonstration projects. The Prevention Market Manager project aggregated and analyzed the project results to inform oral PrEP rollout and new product demonstration projects. Click below for the findings. Two companion documents, Lessons from Seven Early Oral PrEP Demonstration Projects and What…
View All Resources